249 related articles for article (PubMed ID: 12412374)
1. [Genetic, epidemiologic and clinical study of familial prostate cancer].
Valéri A
Bull Acad Natl Med; 2002; 186(4):779-88; discussion 788-91. PubMed ID: 12412374
[TBL] [Abstract][Full Text] [Related]
2. [Epidemiology of familial prostatic cancer: 4-year assessment of French studies].
Valeri A; Drelon E; Azzouzi R; Delannoy A; Teillac P; Fournier G; Mangin P; Berthon P; Cussenot O
Prog Urol; 1999 Sep; 9(4):672-9. PubMed ID: 10555220
[TBL] [Abstract][Full Text] [Related]
3. [Genetic analysis of familial prostatic cancer: localization of a gene predisposing to prostatic cancer (PCaP) on chromosome 1q 42.2-43].
Valeri A; Drelon E; Paiss T; Vogel W; de Petriconi R; Hautmann R; Fournier G; Mangin P; Berthon P; Cussenot O
Prog Urol; 1999 Sep; 9(4):680-8. PubMed ID: 10555221
[TBL] [Abstract][Full Text] [Related]
4. Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer Study.
Cunningham JM; McDonnell SK; Marks A; Hebbring S; Anderson SA; Peterson BJ; Slager S; French A; Blute ML; Schaid DJ; Thibodeau SN;
Prostate; 2003 Dec; 57(4):335-46. PubMed ID: 14601030
[TBL] [Abstract][Full Text] [Related]
5. PCAP is the major known prostate cancer predisposing locus in families from south and west Europe.
Cancel-Tassin G; Latil A; Valéri A; Mangin P; Fournier G; Berthon P; Cussenot O
Eur J Hum Genet; 2001 Feb; 9(2):135-42. PubMed ID: 11313747
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a prostate cancer susceptibility locus on the X chromosome.
Xu J; Meyers D; Freije D; Isaacs S; Wiley K; Nusskern D; Ewing C; Wilkens E; Bujnovszky P; Bova GS; Walsh P; Isaacs W; Schleutker J; Matikainen M; Tammela T; Visakorpi T; Kallioniemi OP; Berry R; Schaid D; French A; McDonnell S; Schroeder J; Blute M; Thibodeau S; Grönberg H; Emanuelsson M; Damber JE; Bergh A; Jonsson BA; Smith J; Bailey-Wilson J; Carpten J; Stephan D; Gillanders E; Amundson I; Kainu T; Freas-Lutz D; Baffoe-Bonnie A; Van Aucken A; Sood R; Collins F; Brownstein M; Trent J
Nat Genet; 1998 Oct; 20(2):175-9. PubMed ID: 9771711
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of prostate cancer in an analysis of linkage to four putative susceptibility loci.
Goode EL; Stanford JL; Peters MA; Janer M; Gibbs M; Kolb S; Badzioch MD; Hood L; Ostrander EA; Jarvik GP
Clin Cancer Res; 2001 Sep; 7(9):2739-49. PubMed ID: 11555587
[TBL] [Abstract][Full Text] [Related]
8. Hereditary aspects of prostate cancer.
McLellan DL; Norman RW
CMAJ; 1995 Oct; 153(7):895-900. PubMed ID: 7553490
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer.
Chang BL; Zheng SL; Isaacs SD; Turner AR; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
Prostate; 2003 Jun; 56(1):37-44. PubMed ID: 12746845
[TBL] [Abstract][Full Text] [Related]
10. Hereditary/familial versus sporadic prostate cancer: few indisputable genetic differences and many similar clinicopathological features.
Alberti C
Eur Rev Med Pharmacol Sci; 2010 Jan; 14(1):31-41. PubMed ID: 20184087
[TBL] [Abstract][Full Text] [Related]
11. Age at diagnosis and age at death in familial prostate cancer.
Brandt A; Bermejo JL; Sundquist J; Hemminki K
Oncologist; 2009 Dec; 14(12):1209-17. PubMed ID: 19939895
[TBL] [Abstract][Full Text] [Related]
12. Luteinizing hormone beta polymorphism and risk of familial and sporadic prostate cancer.
Elkins DA; Yokomizo A; Thibodeau SN; J Schaid D; Cunningham JM; Marks A; Christensen E; McDonnell SK; Slager S; J Peterson B; J Jacobsen S; R Cerhan J; L Blute M; J Tindall D; Liu W
Prostate; 2003 Jun; 56(1):30-6. PubMed ID: 12746844
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer.
Hofer MD; Kuefer R; Maier C; Herkommer K; Perner S; Demichelis F; Paiss T; Vogel W; Rubin MA; Hoegel J
Cancer Res; 2009 Jan; 69(2):640-6. PubMed ID: 19147579
[TBL] [Abstract][Full Text] [Related]
14. Segregation analysis of 389 Icelandic pedigrees with Breast and prostate cancer.
Baffoe-Bonnie AB; Kiemeney LA; Beaty TH; Bailey-Wilson JE; Schnell AH; Sigvaldason H; Olafsdóttir G; Tryggvadóttir L; Tulinius H
Genet Epidemiol; 2002 Nov; 23(4):349-63. PubMed ID: 12432503
[TBL] [Abstract][Full Text] [Related]
15. The complex genetic epidemiology of prostate cancer.
Schaid DJ
Hum Mol Genet; 2004 Apr; 13 Spec No 1():R103-21. PubMed ID: 14749351
[TBL] [Abstract][Full Text] [Related]
16. Epidemiologic and genetic follow-up study of 544 Minnesota breast cancer families: design and methods.
Sellers TA; Anderson VE; Potter JD; Bartow SA; Chen PL; Everson L; King RA; Kuni CC; Kushi LH; McGovern PG
Genet Epidemiol; 1995; 12(4):417-29. PubMed ID: 8536958
[TBL] [Abstract][Full Text] [Related]
17. Role of the Nijmegen breakage syndrome 1 gene in familial and sporadic prostate cancer.
Hebbring SJ; Fredriksson H; White KA; Maier C; Ewing C; McDonnell SK; Jacobsen SJ; Cerhan J; Schaid DJ; Ikonen T; Autio V; Tammela TL; Herkommer K; Paiss T; Vogel W; Gielzak M; Sauvageot J; Schleutker J; Cooney KA; Isaacs W; Thibodeau SN
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):935-8. PubMed ID: 16702373
[TBL] [Abstract][Full Text] [Related]
18. A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: frequent HPCX linkage in families with late-onset disease.
Schleutker J; Matikainen M; Smith J; Koivisto P; Baffoe-Bonnie A; Kainu T; Gillanders E; Sankila R; Pukkala E; Carpten J; Stephan D; Tammela T; Brownstein M; Bailey-Wilson J; Trent J; Kallioniemi OP
Clin Cancer Res; 2000 Dec; 6(12):4810-5. PubMed ID: 11156239
[TBL] [Abstract][Full Text] [Related]
19. [The PROGENE study, the French project of genetic analysis of familial prostatic cancer: recruitment and analysis].
Valeri A; Berthon P; Fournier G; Buzzi JC; Briollais L; Meria P; Blanche H; Bellanne-Chantelot C; Teillac P; Demenais F; Mangin P; Cohen N; Le Duc A; Cussenot O
Prog Urol; 1996 Apr; 6(2):226-35. PubMed ID: 8777415
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families.
Xu J; Gillanders EM; Isaacs SD; Chang BL; Wiley KE; Zheng SL; Jones M; Gildea D; Riedesel E; Albertus J; Freas-Lutz D; Markey C; Meyers DA; Walsh PC; Trent JM; Isaacs WB
Prostate; 2003 Dec; 57(4):320-5. PubMed ID: 14601028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]